Financial Snapshot
This section of the Fusion Pharmaceuticals InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing.
Please note: All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes. Fusion Pharmaceuticals assumes no responsibility for the accuracy of this data and provides it for informational purposes only.
NASDAQFUSN
| Beta | (0.17) |
|---|---|
| Shares Outstanding | 43.0M |
| Average Volume (10 days) | 79.3K |
| Qtrly Dividend (Ann. Yield) | -- (--) |
Analyst Views
| Current Mean Recommendation | Strong Buy |
|---|
| Strong Buy | 5 | |
|---|---|---|
| Buy | 1 | |
| Hold | 0 | |
| Underperform | 0 | |
| Sell | 0 |
Recent Insider Transactions
Steven Gannon Director | 2,829 Buy Aug 23, 2021 |
|---|---|
Steven Gannon Director | 3,000 Buy Aug 19, 2021 |
Steven Gannon Director | 171 Buy Aug 18, 2021 |
Steven Gannon Director | 6,000 Buy Aug 16, 2021 |
Heather Preston Director | 8,823 Buy Jun 30, 2020 |
NEVER MISS AN UPDATE
